Impax CEO’s Strategy: Aggressive BD, Restructure R&D And Cut Costs
This article was originally published in The Pink Sheet Daily
Executive Summary
Since Impax Laboratories’ CEO Wilkinson took the helm in April, the company has completed several significant deals and most recently restructured R&D to deliver savings, but a successful turnaround will require resolving outstanding manufacturing issues.